Biomedical applications of iron oxide nanoparticles: Current insights progress and perspectives

MG Montiel Schneider, MJ Martín, J Otarola… - Pharmaceutics, 2022 - mdpi.com
The enormous development of nanomaterials technology and the immediate response of
many areas of science, research, and practice to their possible application has led to the …

[HTML][HTML] Magnetic nanoparticles in cancer theranostics

OL Gobbo, K Sjaastad, MW Radomski, Y Volkov… - Theranostics, 2015 - ncbi.nlm.nih.gov
In a report from 2008, The International Agency for Research on Cancer predicted a tripled
cancer incidence from 1975, projecting a possible 13-17 million cancer deaths worldwide by …

[HTML][HTML] Nanomedicine therapeutic approaches to overcome cancer drug resistance

JL Markman, A Rekechenetskiy, E Holler… - Advanced drug delivery …, 2013 - Elsevier
Nanomedicine is an emerging form of therapy that focuses on alternative drug delivery and
improvement of the treatment efficacy while reducing detrimental side effects to normal …

[HTML][HTML] Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR

IS Mohammad, W He, L Yin - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Indeed, multi-drug resistance (MDR) is a significant obstacle to effective chemotherapy. The
overexpression of ATP-binding cassette (ABC) membrane transporters is a principal cause …

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

S Liu, AR Khan, X Yang, B Dong, J Ji, G Zhai - Journal of Controlled …, 2021 - Elsevier
Multidrug resistance (MDR) of cancer is a persistent problem in chemotherapy. Scientists
have considered the overexpressed efflux transporters responsible for MDR and …

Innovative nano-carriers in anticancer drug delivery-a comprehensive review

P Dong, KP Rakesh, HM Manukumar… - Bioorganic …, 2019 - Elsevier
In the scientific field, nanotechnology has offered multipurpose and designated functional
nanoparticles (NPs) for the development of applications in nano-medicine. This present …

Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy

A Borah, S Raveendran, A Rochani, T Maekawa… - Oncogenesis, 2015 - nature.com
Extensive cancer research in the past few decades has identified the existence of a rare
subpopulation of stem cells in the grove of cancer cells. These cells are known as the cancer …

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells

R Sun, Y Liu, SY Li, S Shen, XJ Du, CF Xu, ZT Cao… - Biomaterials, 2015 - Elsevier
Combination treatment through simultaneous delivery of two or more drugs with
nanoparticles has been demonstrated to be an elegant and efficient approach for cancer …

Inorganic nanocarriers overcoming multidrug resistance for cancer theranostics

G Lin, P Mi, C Chu, J Zhang, G Liu - Advanced science, 2016 - Wiley Online Library
Cancer multidrug resistance (MDR) could lead to therapeutic failure of chemotherapy and
radiotherapy, and has become one of the main obstacles to successful cancer treatment …

Recent progress in iron oxide nanoparticles as therapeutic magnetic agents for cancer treatment and tissue engineering

M Nabavinia, J Beltran-Huarac - ACS Applied Bio Materials, 2020 - ACS Publications
The positive response of superparamagnetic iron oxide nanoparticles (SPIONs), in terms of
biodegradability, circulation, elimination, toxicity, and manipulation of their structure/activity …